Optic Neuritis clinical trials at UCSF
1 research study open to eligible people
Optic neuritis is an eye condition that causes inflammation of the optic nerve. UCSF is studying clemastine fumarate to see if it can help repair the nerve damage in people with this condition. These trials are recruiting participants to learn more about potential treatments for optic neuritis.
Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
open to eligible people ages 18-55
The main purpose of this study is to assess clemastine as a remyelinating agent in patients with acute optic neuritis.The study will also evaluate the tolerability of clemastine, originally approved as first-generation antihistamine, in patients…
San Francisco, California
Our lead scientists for Optic Neuritis research studies include Ari Green, MD, MCR.
Last updated: